Robert P. Roche Jr., Executive VP, WW Pharmaceutical Operations at CEPHALON INC (CEPH), sold 5,355 shares at $75.42 ($396K) on 2007-11-28, disclosed to the SEC on 2007-11-28.
Open-market sale of $396k CEPH by Executive VP, WW Pharmaceutical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10 | $0 | 0.0% |
| 2 | $0.00 | 20 | $0 | 0.0% |
| 3 | $0.00 | 70 | $0 | 0.0% |
| 4 | $75.26 | 175 | $13K | 3.3% |
| 5 | $75.27 | 1,280 | $96K | 24.3% |
| 6 | $75.30 | 1,300 |
| $98K |
| 24.7% |
| 7 | $75.32 | 300 | $23K | 5.7% |
| 8 | $75.33 | 200 | $15K | 3.8% |
| 9 | $75.35 | 2 | $151 | 0.0% |
| 10 | $75.36 | 100 | $8K | 1.9% |
| 11 | $75.39 | 200 | $15K | 3.8% |
| 12 | $75.40 | 600 | $45K | 11.4% |
| 13 | $75.41 | 698 | $53K | 13.3% |
| 14 | $75.42 | 400 | $30K | 7.6% |
| Total | $73.93 avg | 5,355 | $396K | 100% |
| Filing → |
| ATRS | BUY | 2015-08-17 | $10K | — | Filing → |
| ATRS | BUY | 2014-08-14 | $10K | — | Filing → |
| PATH | BUY | 2011-09-19 | $27K | — | Filing → |